If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Cristina Giogha obtained her B. Sc. (Hons) majoring in microbiology and immunology from the University of Melbourne in 2011. She received an Australian Postgraduate Award scholarship to commence her PhD within the laboratory of Professor Elizabeth Hartland in 2012 and was awarded her degree at the University of Melbourne in 2017. She began a postdoctoral position with Prof Hartland in 2017 and is currently Leader of gastrointestinal infection research within the Hartland laboratory at the Hudson Institute of Medical Research, where she supervises two PhD students. In 2018 she was awarded one of six prestigious Victoria Fellowships in the Life Sciences category, which supported her during a two month study mission at Weill Cornell Medicine, New York where she received training in genetic editing of intestinal organoids. In 2019 she was nominated as a Hudson Institute Emerging Leader and is taking part in the inaugural Leadership Program in 2020.

Education/Academic qualification

Doctor of Philosophy (Microbiology), University of Melbourne

Award Date: 1 Jan 2017

B. Science with Honours, University of Melbourne

Award Date: 1 Jan 2011

B. Science (Microbiology & Immunology major), University of Melbourne

Award Date: 1 Jan 2010

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Salmonella effectors SseK1 and SseK3 target death domain proteins in the TNF and TRAIL signaling pathways

Newson, J., Scott, N. E., Chung, I. Y. W., Lung, T. W. F., Giogha, C., Gan, J., Wang, N., Strugnell, R., Brown, N. F., Cygler, M., Pearson, J. & Hartland, E., 1 Jun 2019, In : Molecular & Cellular Proteomics. 18, 6, p. 1138-1156 19 p.

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Sugar Fix Keeps RIPK3 at Bay

Giogha, C. & Lawlor, K. E., 19 Mar 2019, In : Immunity. 50, 3, p. 539-541 3 p.

Research output: Contribution to journalShort SurveyOtherpeer-review

Distinct roles of the antiapoptotic effectors NleB and NleF from enteropathogenic Escherichia coli

Pollock, G. L., Oates, C. V. L., Giogha, C., Lung, T. W. F., Ong, S. Y., Pearson, J. S. & Hartland, E. L., 1 Apr 2017, In : Infection and Immunity. 85, 4, 12 p., e01071-16.

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammation

Pearson, J. S., Giogha, C., Mühlen, S., Nachbur, U., Pham, C. L. L., Zhang, Y., Hildebrand, J. M., Oates, C. V., Lung, T. W. F., Ingle, D. J., Dagley, L. F., Bankovacki, A., Petrie, E. J., Schroeder, G. N., Crepin, V. F., Frankel, G., Masters, S. L., Vince, J., Murphy, J. M., Sunde, M. & 3 others, Webb, A. I., Silke, J. & Hartland, E. L., 13 Jan 2017, In : Nature Microbiology. 2, 10 p., 16258.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
56 Citations (Scopus)

The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD)

Scott, N. E., Giogha, C., Pollock, G. L., Kennedy, C. L., Webb, A. I., Williamson, N. A., Pearson, J. S. & Hartland, E. L., 2017, In : The Journal of Biological Chemistry. 292, 42, p. 17337-17350 14 p.

Research output: Contribution to journalArticleResearchpeer-review

21 Citations (Scopus)